Antibody · 흑색종

42개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved42 programs
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

Ipilimumab Injection [Yervoy] (Ipilimumab Injection [Yervoy])

Malignant Melanoma · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

Ipilimumab and Fotemustine (Ipilimumab and Fotemustine)

Metastatic Malignant Melanoma · Metastatic Malignant Melanoma

#MetastaticMalignantMelanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab plus nivolumab plus guadecitabine)

Melanoma; Non Small Cell Lung Cancer · Melanoma

#Melanoma#Antibody#Phase2#monoclonal-antibody#NonSmallCellLungCancer+1
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab)

Metastatic Cancer; Melanoma Cancer · Metastatic Cancer

#MetastaticCancer#Antibody#Phase2#monoclonal-antibody#MelanomaCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBrown UniversityPhase 2

Ipilumumab (Ipilumumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#monoclonal-antibody#Brown
Trials 1Status Recruiting
AntibodyLimited DatastaleOslo University HospitalPhase 2

pembrolizumab (Keytruda, LTX-315 + pembrolizumab)

Melanoma Stage IIIB-IV · Melanoma Stage IIIB-IV

#MelanomaStageIIIB-IV#Antibody#Phase2#monoclonal-antibody#Oslo
Trials 1Status Recruiting
AntibodyLimited DatastaleIovance Biotherapeutics, Inc.Phase 3

pembrolizumab (Keytruda, Lifileucel plus Pembrolizumab)

Metastatic Melanoma; Unresectable Melanoma · Metastatic Melanoma

#MetastaticMelanoma#Antibody#Phase3#monoclonal-antibody#UnresectableMelanoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNYU Langone HealthPhase 1

nivolumab (Opdivo, Mocetinostat Induction Phase + Ipilimumab + Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase1#monoclonal-antibody#NYU
Trials 1Status Discontinued
AntibodyLimited DatastaleNYU Langone HealthPhase 1

nivolumab (Opdivo, Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase1#monoclonal-antibody#NYU
Trials 1Status Discontinued
AntibodyLimited DatastaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Neoadjuvant ipilimumab + nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#monoclonal-antibody#Bristol
Trials 1Status Recruiting
AntibodyLimited DatastaleWashington University School of…Phase 1

Relatilmab (Relatilmab)

Advanced Melanoma; Metastatic Melanoma · Advanced Melanoma

#AdvancedMelanoma#Antibody#Phase1#monoclonal-antibody#MetastaticMelanoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Schedule Finding Triplet: Combination of NKTR-214+ nivolumab+ ipilimumab)

Melanoma; Renal Cell Carcinoma · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#Melanoma+2
Trials 1Status Active
AntibodyLimited DatastaleChia Tai Tianqing Pharmaceutica…Phase 2

TQB2922 injection+TAS-102 tablets ± Bevacizumab (TQB2922 injection+TAS-102 tablets ± Bevacizumab)

RAS/BRAF Wild Type Colorectal Cancer · RAS/BRAF Wild Type Colorectal Cancer

#RASBRAFWildTypeColorectalCancer#Antibody#Phase2#monoclonal-antibody#RAS+2
Trials 1Status Recruiting
AntibodyLimited DatastaleImmunocore LtdPhase 3

pembrolizumab (Keytruda, Tebentafusp with Pembrolizumab)

Advanced Melanoma · Advanced Melanoma

#AdvancedMelanoma#Antibody#Phase3#monoclonal-antibody#Immunocore
Trials 1Status Recruiting
AntibodyLimited DatastaleXencor, Inc.Phase 1

XmAb®22841 (XmAb®22841)

Melanoma; Cervical Carcinoma · Melanoma

#Melanoma#Antibody#Phase1#monoclonal-antibody#CervicalCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleXencor, Inc.Phase 1

XmAb®23104 (XmAb®23104)

Melanoma (Excluding Uveal Melanoma); Cervical Carcinoma · HER2

#HER2#Antibody#Phase1#monoclonal-antibody#MelanomaExcludingUvealMelanoma+2
Trials 1Status Active
AntibodyLimited DatastaleXencor, Inc.Phase 1

XmAb®808 (XmAb®808)

Head and Neck Squamous Cell Carcinoma; Melanoma Excluding Uveal Melanoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase1#monoclonal-antibody#MelanomaExcludingUvealMelanoma+1
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 1

ipilimumab (Yervoy®, Yervoy® (ipilimumab))

Melanoma (Excluding Uveal Melanoma); Cervical Carcinoma · HER2

#HER2#Antibody#Phase1#monoclonal-antibody#MelanomaExcludingUvealMelanoma+2
Trials 1Status Active
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Ziv-Aflibercept)

Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Colorectal Carcinoma · FRα

#FR#Antibody#Phase1#monoclonal-antibody#ClinicalStageIVCutaneousMelanoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, relatlimab+nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 1Status Active

2 / 3 pages

← PreviousNext →